Danaher Corporation (ETR:DAP)
Germany
· Delayed Price · Currency is EUR | Market Cap | 119.44B |
| Revenue (ttm) | 21.99B |
| Net Income (ttm) | 3.48B |
| Shares Out | n/a |
| EPS (ttm) | 4.76 |
| PE Ratio | 34.36 |
| Forward PE | 23.72 |
| Dividend | 1.05 (0.63%) |
| Ex-Dividend Date | Mar 28, 2025 |
| Volume | 263 |
| Average Volume | 1,257 |
| Open | 164.96 |
| Previous Close | 167.02 |
| Day's Range | 164.96 - 168.76 |
| 52-Week Range | 149.72 - 260.00 |
| Beta | 0.83 |
| RSI | 44.53 |
| Earnings Date | Jul 22, 2025 |
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manuf... [Read more]
Financial Performance
In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.
Financial numbers in USD Financial StatementsNews
Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI
Michael Yee, Jefferies senior biotech analyst, joins CNBC's 'Squawk on the Street' to discuss how AI could fuel drug discovery and development, the timeline for when pharmaceutical companies could see...
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Danaher (NYSE: DHR) has outperformed the market over the past 10 years by 1.68% on an annualized basis producing an average annual return of 12.54%. Currently, Danaher has a market capitalization of ...
Market Whales and Their Recent Bets on DHR Options
High-rolling investors have positioned themselves bearish on Danaher (NYSE: DHR), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tra...
P/E Ratio Insights for Danaher
Looking into the current session, Danaher Inc. (NYSE: DHR) shares are trading at $197.77, after a 0.69% spike. Moreover, over the past month, the stock increased by 2.97% , but in the past year, decr...
Third Point adds US Steel, Kenvue, exits Danaher, Tesla among Q1 moves
Discover Third Point's latest investment moves in Q1: new stakes in US Steel & Nvidia, exits from Tesla & Danaher, and shifts across tech & industrial giants.
Danaher Corporation (DHR) BofA Securities 2025 Healthcare Conference (Transcript)
Danaher Corporation (NYSE:DHR) BofA Securities 2025 Healthcare Conference May 15, 2025 1:00 PM ETCompany ParticipantsRainer Blair - CEOConference Call...
Danaher to Present at Bank of America Securities Healthcare Conference
WASHINGTON , May 7, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the at the Bank of America Securit...
Danaher Announces Quarterly Dividend
WASHINGTON , May 6, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common sto...
Danaher Announces Quarterly Dividend
WASHINGTON , May 6, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common sto...
Danaher: A Capital Intensive Business Offering Low Risk, Low Reward Opportunity
Dan Rohinton's Top Picks: Amazon, GE Aerospace & Danaher
Dan Rohinton, vice-president and portfolio manager at iA Global Asset Management, shares his top stock picks to watch in the market.
At Danaher, Christopher Paul Riley Chooses To Exercise Options, Resulting In $955K
A large exercise of company stock options by Christopher Paul Riley , Executive Vice President at Danaher (NYSE: DHR) was disclosed in a new SEC filing on May 1, as part of an insider exercise. What ...
Danaher: Q1 Beat Fails To Trigger Guidance Upgrade
Baron Health Care Fund Q1 2025 Top Contributors And Detractors
Boston Scientific's shares rose due to strong market growth, innovative products like pulsed field ablation, and disciplined cost management, driving double-digit EPS growth. Vertex Pharmaceuticals sa...
Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow
Kytopen and Aldevron announce collaboration to expedite cell therapy manufacturing by combining their novel technologies. High transgene expression and improved safety profile of Aldveron's Nanoplasmi...
Analyst Sees Opportunity In Danaher Stock As Sentiment Improves
Danaher Corp (NYSE: DHR) on Tuesday reported first-quarter 2025 sales of $5.74 billion, down 1% year-over-year, beating the consensus of $5.59 billion . Non-GAAP core revenue was flat compared to the...
Three ideas to invest amid the trade war
Dan Rohinton, portfolio manager at iA Global Asset Management, has three ideas to invest amid the trade war: Danaher, GE Aerospace & CME Group.
Danaher's quarterly results show signs of life, and the struggling stock soars
Count us among the Danaher investors breathing a sigh of relief.
Danaher outlines 3% core revenue growth and $7.60-$7.75 EPS guidance for 2025
Danaher Corporation 2025 Q1 - Results - Earnings Call Presentation
The following slide deck was published by Danaher Corporation in conjunction with their 2025 Q1 earnings call.
Danaher Corporation (DHR) Q1 2025 Earnings Call Transcript
Danaher Corporation (NYSE:DHR) Q1 2025 Earnings Conference Call April 22, 2025 8:00 AM ETCompany ParticipantsJohn Bedford - VP, IRRainer Blair - President...
Quest Diagnostics Posts Better-Than-Expected Earnings, Joins Pentair, 3M, Danaher And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index gaining around 600 points on Tuesday. Shares of Quest Diagnostics Incorporated (NYSE: DGX) rose sharply during Tuesday's session following better-tha...
Danaher Makes A Bullish Move On 'Solid' Report, Promising Tariffs Plan
Danaher stock jumped Tuesday after the medical powerhouse delivered a "solid" first-quarter report and maintained its outlook for the year.
Danaher Beats Q1 Expectations, Signals Caution Ahead In 'Unusual Times'
Danaher Corp (NYSE: DHR) on Tuesday reported first-quarter 2025 sales of $5.74 billion, down 1% year-over-year, beating the consensus of $5.59 billion . Non-GAAP core revenue was flat compared to the...
Danaher Beats Q1 Expectations, Signals Caution Ahead In 'Unusual Times'
Danaher Corp DHR on Tuesday reported first-quarter 2025 sales of $5.74 billion, down 1% year-over-year, beating the consensus of $5.59 billion.